HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.
about
Nintedanib in NSCLC: evidence to date and place in therapyDaxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis.Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionRoles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis.Drug repositioning discovery for early- and late-stage non-small-cell lung cancer.Alveolar hypoxia promotes murine lung tumor growth through a VEGFR-2/EGFR-dependent mechanismVEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations[(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxiaMicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signalingLong non-coding RNAs in cancer invasion and metastasis.Stimulating immune responses to fight cancer: Basic biology and mechanisms.Bevacizumab in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for first-line and maintenance treatment of metastatic colorectal cancer.Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena.HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells.Long Non-coding RNAs and their Role in Metastasis.Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion.(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.
P2860
Q26745424-8465FF97-592D-45E7-BEE0-785D9B00C0BFQ30833310-1EBBAE8E-433B-4CFF-AFC2-5BF1E0D22079Q33588186-A1097229-8F80-438C-8B2E-97A947B2F6F7Q33946123-951FD683-4E63-4B8D-8CC2-9B966BA7EA5DQ33960142-808EFB02-732A-447E-A434-223D6123CAA6Q34145973-65813F86-058D-480B-9020-71F2AF752D7CQ34213977-792867D2-FFD5-4082-B29B-A00F375919EBQ36216197-5ECD948F-386E-4EA4-BD3F-0698BDAE1CEEQ36414969-18027D36-0C3D-488C-8864-AD4DA84488A8Q37694851-35F696D2-974E-4443-8339-1D753EC78955Q38219896-153FB2E0-F08E-4EEF-8FAE-4F096B19EC4EQ38578898-2BB9C3F8-0A19-46E5-9851-A2D16CA1B3EAQ38617495-CE3A832F-EA3E-42B0-8D6B-9BDE11A4DDC4Q38645336-44D88743-DDE7-4FA3-9482-9D9F30D8D976Q38696908-D94424FB-F3C4-47F6-A7C2-F783C3FCC9D3Q38818070-9C4ACAA9-2FF6-40C6-8495-10510637C314Q38862385-6F887C81-6EE4-4DBA-9F6E-1A6A199CC3F9Q39029459-168D65E0-0518-48C9-B925-B0152703422BQ39215796-F4266ECF-5B5E-428A-B38A-77E8F70CCF32Q41709272-88EBBD49-AE25-4ABE-93E3-7B77D24F4CD9
P2860
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.
@en
type
label
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.
@en
prefLabel
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.
@en
P2093
P2860
P1476
HIF, hypoxia and the role of angiogenesis in non-small cell lung cancer.
@en
P2093
Autumn L Jackson
William Y Kim
P2860
P304
P356
10.1517/14728222.2010.511617
P407
P577
2010-10-01T00:00:00Z